Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model via the regulation of uric acid metabolism
Bone marrow transplantation Eight-week-old male recipient mice were housed in filter-top cages and provided with sterile water containing 1000 U/L polymyxin B and 1.1 mg/L neomycin for one week prior to receiving total body irradiation (6 Gy)
To better understand the clinical utility of flavonoids and assess their potential as adjunctive therapies, the following areas need to be further investigated: structural optimization, drug targeting, and inhalation delivery systems, standardized research reporting, and multi-omics data integration, along with rigorous multicenter clinical trials and comprehensive safety evaluations
A history of severe reflux, bariatric surgery, opioid use, Parkinson disease, scleroderma, gastric outlet obstruction, or long-standing diabetes should raise suspicion for baseline motility impairment